Putting you at the heart of everything

It's been a challenging few weeks for the UK life sciences sector. Following the breakdown of the talks with the Government to provide a more competitive reimbursement scheme for pharma, there have been a number of high-profile decisions that have created big concerns for the future of the sector. However, there have been some good news stories too, including a resilient message from MedCity - the life sciences arm of London and Partners, with whom VWV is a partner.

Legal considerations and practical tips for businesses in the pharmaceuticals and life sciences sector.

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that it is developing a new strategy to provide its direction, mission, values and focus through to 2030. What should we expect?

Reports suggest the government is considering reintroducing modest fees for employment tribunal and appeal claims, though no decision has yet been made.

Provisions in non-disclosure agreements that prevent victims of criminal conduct from sharing information with certain people are now void under new legislation.

The Employment Appeal Tribunal has ruled on whether a member of the public could obtain documents after remotely observing a hearing. The case highlights the balance between transparency and protecting privacy in employment cases.

The Employment Appeal Tribunal has provided clarity on how commission schemes operate, highlighting the importance of well-drafted commission clauses and clear rules on apportioning team effort.

The Employment Rights Bill, introduced to Parliament on 10 October 2024, proposes significant reforms across various aspects of employment law. Below is a summary of key provisions, organised by topic:

HMRC has released guidance on upcoming reforms to the treatment of umbrella companies, ahead of legislative changes due in April 2026.